Details for New Drug Application (NDA): 062562
✉ Email this page to a colleague
NDA 062562 describes AMIKIN, which is a drug marketed by Apothecon and is included in four NDAs. Additional details are available on the AMIKIN profile page.
The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
Summary for 062562
| Tradename: | AMIKIN |
| Applicant: | Apothecon |
| Ingredient: | amikacin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062562
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/ML | ||||
| Approval Date: | Sep 20, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/ML | ||||
| Approval Date: | Sep 20, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
